Ann: Two more PANCOSIL Trial treatments using OncoSil device, page-168

Hey Gekko,

where are you going with this Telix stuff ?

Just weighing in with my take here—I reckon Oncosil is on the brink of something potentially big. I'm predicting that if they can hit the targets of either 1 million in revenue or 100 sales within the year, we could be looking at a re-valuation of the company around 100-200 million.

Even beforehand, if some interesting things happen, we could reach 85m.

It seems like there's a substantial line of investors already keeping a close eye on this, suggesting that the market senses momentum too.

Quite a few people want this to succeed, including the CEO. - Needless to say, Nigel has a large number of incentives lined up, He is seriously motivated to deliver success.

In my humble opinion, these achievements could really shift the needle and bring Oncosil closer to that valuation mark. Curious to hear your thoughts on this, Gekko.

Do you see it playing out similarly, or have you got a different view on the trajectory?

Cheers Ozzy